Vitiligo therapy

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 17, 2009, Pages 2779-2785

  Lotti, Torello ^a   Berti, Samantha ^a   Moretti, Silvia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Combination therapy; Microphototherapy; NB UVB; Vitiligo

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; EFALIZUMAB; FATTY ACID; MEQUINOL; MONOBENZONE; PHENYLALANINE; PIMECROLIMUS; POLYPODIUM LEUCOTOMOS EXTRACT; PROSTAGLANDIN E; PSORALEN; TACROLIMUS; THIOCTIC ACID;

ADOLESCENT; ADULT; CLINICAL TRIAL; CRYOTHERAPY; DEPIGMENTATION; HUMAN; HYPERPIGMENTATION; INFECTION; KELOID; PHOTOTHERAPY; PUVA; REVIEW; SCAR FORMATION; SKIN GRAFT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT; VITILIGO;

DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; VITILIGO;

EID: 73149119601     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903357509     Document Type: Review

References (60)

1. Huggins RH, Schwartz RA, Janniger CK. Childhood vitiligo. Cutis 2007;79:277-280
2. Lotti T, Gori A, Zanieri F, et al. Vitiligo: New and emerging treatments. Dermatol Ther 2008;21:110-117
3. Hu Z, Liu JB, Ma SS, et al. Profile of childhood vitiligo in China: An analysis of 541 patients. Pediatr Dermatol 2006;23:114-116
4. Iacovelli P, Sinagra JL, Vidolin AP. Relevance of thryroiditis and other autoimmune diseases in children with vitiligo. Dermatology 2005;210:26-30
5. Pajvani U, Ahmad N, Wiley A, et al. The relationship between family medical history and childhood vitiligo. J Am Acad Dermatol 2006;55:238-244
6. Van der Wijngaard RM, Aten J, Sheepmaker A, et al. Expression and modulation of apoptosis regulatory molecules in human melanocyte: Significance in vitiligo. Br J Dermatol 2000;143:573-581
7. Lotti T, Prignano F, Buggiani G. New and experimental treatments of vitiligo and other hypomelanoses. Dermatol Clin 2007;25:393-400, (review of different therapeutical modalities) (Pubitemid 47088895)
8. Whitton ME, Ashcroft DM, Gonzales U. Therapetic interventions for vitiligo. J. Am Acad Dermatol 2008;59:713-717
9. Hirobe T. The role of keratinocytes derived factors involved in the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res 2005;18:2-12
10. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo in UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997;133:1525-1528
11. Jones SS, Palmer RA; Garibaldinos TM, Hawk JL. Randomized double-blind trial of treatment of vitiligo: Efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy. Arch Dermatol 2007;143(5):578-584
12. Njoo MD, Bos JD, Westerhof W. Treatment generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000;42:245-253
13. Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol 2005;30:332-336
14. Kunisada M, Kumimoto H, Ishizaki K, et al. Narrow-Band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer. J Invest Dermatol 2007;127:2865-2871
15. Menchini G, Tsoureli-Nikita E, Hercogova. Narrowband UV-B microphototherapy: A new treatment of vitiligo. J Eur Acad Dermatol Venereol 2003;17:171-177
16. Martin JA, Laube S, Edwards C, et al. Rate of acute adverse events for narrow-band UVB and psoralen-UVA phototherapy. Photodermatol Photoimmunol Photomed 2007;23:68-72
17. Lotti T, Buggiani G, Troiano M, et al. Targeted and combination treatments for vitiligo. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol Ther 2008;21:S20-6
18. Lotti T, Rossi R, Campolmi P. Targeted UV-B phototherapy: When and why to start. Arch Dermatol 2006;142:933-934
19. Hercogova J, Buggiani G, Prignano F, Lotti T. A rational approach to the treatment of vitiligo and other hypomelanoses. Dermatol Clin 2007;25:383-392 (Pubitemid 47088894)
20. Esposito M, Soda R, Costanzo A, Cimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol 2004;29:133-137
21. Passeron T, Ortonne JP. Use of the 308-nm excimer laser for psoriasis and vitiligo. Clin Dermatol 2006;24:33-42
22. Passeron T, Ortonne JP. The 308 nm excimer laser in dermatology. Presse Med 2005;34:301-309
23. Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light in the treatment of vitiligo: A pilot study. J Eur Acad Dermatol Venereol 2003;17:531-537
24. Chimento SM, Newland M, Ricotti C, et al. A pilot study to determine the safety and the efficacy of monochromatic excimer light in the treatment of vitiligo. J Drugs Dermatol 2008;7:258-263
25. Kollner K, Wimmershoff MB, Hintz C, et al. Comaprison of 308-nm excimer laser and 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the ttreatment of psoriasis. Br J Dermatol 2005;152:750-754
26. Yu HS, Wu CS, Yu CL, et al. Helium-neon laser irratiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo. J Invest Dermatol 2003;120:56-64
27. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Paired comparison study on narrow band (TL-01) UVB phototherapy versus photochemotherapy (PUVA) in the treatment of chronic plaque type psoriasis. Arch Dermatol 1999;135:519-524
28. Mai DW, Omohundro C, Dijkstra JW, Bailin PL. Childhood vitiligo successfully treated with bath PUVA. Pediatr Dermatol 1998;15:53-55
29. Forschner T, Buchholtz S, Stockfleth E. Current state of vitiligo therapy - evidence-based analysis of the literature. J Dtsch Dermatol Ges 2007;5:467-475
30. Kwinter J, Pelletier J, Khambalia A, Pope E. High-potency steroid use in children with vitiligo: A retrospective study. J Am Acad Dermatol 2007;56:236-241
31. Grimes PEMorris S, Avaniss-Aghajani E, Soriano T, et al. Topical tacrolimus therapy for vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004;51:52-61
32. Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308 nm excimer laser. A synergistic combination for treatment of vitiligo. Arch Dermatol 2004;140:1065-1069
33. Hartmann A, Brocker EB, Hamm H. Occlusive treatment enhances the efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: Results of a placebo-controlled 12-month prospective study Acta Derm. Venereol 2008;88:474-479
34. Berti S, Buggiani G, Lotti T. Use of tacrolimus ointment in vitiligo alone or in combination therapy. Skin Ther Lett 2009;4:5-7
35. Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The efficacy of pimecrolimus 1% cream plus narrow-band nultraviolet B in the treatment of vitiligo: A double-blind, placebo-controlled clinical trial. J Dermatol Treat 2008;16:1-5
36. Travis LB, Silverberg NB. Calcipotriene and corticosteroid combination therapy for vitiligo. Pediatr Dermatol 2004;21:495-498
37. Leone G, Pacifico A. Profile of clinical efficay and safety of topical tacalcitol. Acta Biomed 2005;76:13-19
38. Gargoom AM, Duweb GA, Elzorghany AH, et al. Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res 2004;24:11-14
39. Kieffer MA. Topical vitamin D analogs. Dermatol Nurs 2004;16:89-90
40. Rodriguez-Martin M, Gartcia Bustinduy M, Saez Rodriguez M, Nola Cabrera A. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo. Br J Dermatol 2009;!60:409-414
41. Leone G, Pacifico A, Iacovelli P, et al. Tacacitol and narrow-band phototherapy in patients with vitiligo. Clin Exp Dermatol 2006;31:200-205
42. Lu-yan T, Wen-wen F, Lei-hong X, et al. Topical tacalcitol and 308-nm monochromatic excimer light: A synergistic combination for the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2006;22:310-314
43. Parsad P, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol 2004;50:63-67
44. Baysal W, Yildirim M Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur Acad Dermatol Venereol 2004;17:299-302
45. Hasse S, Gibbons NC, Rokos H, et al. Perturbed 6-tetrahydrobiopterin recycling via decreased dihydrobiopteridine reductase in vitiligo: More evidence for H2O2 stress. J Invest Dermatol 2004;122:307-313
46. Schallreuter KU. Effectiveness of pseudocatalase formulations in vitiligo. Clin Exp Dermatol 2003;28:562-563
47. Khemis A, Ortonne JP. Etude comparative d'un extrait vegetal possedand une activité superoxide dismutase (VITIX-) plus phototherapie UVB selective versus son excipient plus phototherapie selective dans le traitment du vitiligo vulgaire. Nouvelle Dermatologique 2004;23:7-11
48. Spencer JD, Gibbons NCJ, Rokos H, et al. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 2007;127:411-420
49. Dell'Anna ML, Mastrofrancesco A, Sala R, et al. Antioxidants and narrow band UVB in the treatment of vitiligo: A double blind placebo controlled trial. Clin Exp Dermatol 2007;32:631-636
50. Middelkamp-Hup MA, Bos JD, Rius-Diaz F, et al. Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: A randomized trial double-blind placebo-controlled study. J Eur Dermatol Venereol 2007;21:942-950
51. Parsad D, Pandhi R, Dogra S, Kumas B. Topical prostaglandin analog (PGE2) in vitiligo: Preliminary study. Int J Dermatol 2002;41:942-945
52. Wakke M, Assen YJ, Thio HB, Neumann AM. Repigmentation of vitiligo during efalizumab. J Am Acad Dermatol 2008;59:S57-8
53. Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with 4-methoxyphenol and Q-switched ruby laser. J Am Acad Dermatol 2000;42:760-769
54. Radmanesh M. Depigmentation of the normally pigmented patches in universal vitiligo patients with cryotherapy. J Eur Acad Dermatol 2000;14:149-152
55. Chen YF, Yang PY, Hu DN, et al. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: Analysis of 120 cases. J Am Acad Dermatol 2004;51:68-74
56. Rusfianti M, Wirohadidjodjo YW. Dermosurgical techniques for repigmentation of vitiligo. Dermatol Surg 2006;32:387-391
57. Gupta S, Kumar B. Epidermal grafting in vitiligo: Influence of age, site of lesion, and type of disease on outcome. J Am Acad Dermatol 2003;49:99-104
58. Leachman S. Surgical therapies. Part III. Melanocyte transplants. Dermatol Ther 2001;14:20-28
59. Pianigiani E, Andreassi A, Andreassi L. Autografts and cultured epidermis in the treatment of vitiligo. Clin Dermatol 2005;23:424-429
60. Andreassi A, Pianigiani E, Taddeucci P, et al. Tissue-engineered skin in the treatment of vitiligo lesions. In: Lotti T, Hercogova J, editors, Vitiligo: Problems and solutions Marcel Dekker, Inc, New York, USA; 2004. p. 313-321